| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2094318 | EIF2B2 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 14 | - |
PV=1 FDR=1 FC=0.132 |
|
| 2094319 | EIF2B2 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 14 | - |
PV=1 FDR=1 FC=0.046 |
|
| 2094320 | SLC17A9 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 20 | - |
PV=1 FDR=1 FC=-0.01 |
|
| 2094321 | ZNF160 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 19 | - |
PV=1 FDR=1 FC=-0.025 |
